– UK, Village Alva – Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that Colin King has agreed to join the Board as Chief Operating Officer and will take up his appointment with effect from 3 August 2015.
Mr King has over 20 years’ experience in the in-vitro diagnostics industry and is currently the Managing Director of Axis-Shield Diagnostics, having joined in 1995 and held a number of positions encompassing project management, operations, planning and supply chain logistics.
Andrew Shepherd, Chief Executive of the Company said:”We would like to welcome Colin to the Board. He brings a wealth of relevant industry experience and his depth of knowledge of the in-vitro diagnostics sector will further strengthen the Omega Board.”
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.